Anti-CDCP1/CD318 Antibody (38 E11) is a potent monoclonal antibody targeting the extracellular domain of the transmembrane glycoprotein CDCP1, acting by specifically binding to its CUB1 domain. The compound is an essential tool for investigating Src-dependent signaling, tumor cell survival, and distal metastasis mechanisms, aiming to downregulate downstream oncogenic signaling cascades by blocking CDCP1 phosphorylation or inducing its internalization.
Target:
Others
T9901A-1455
* VAT and and shipping costs not included. Errors and price changes excepted
